Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Ovarian Cancer × liposomal doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 52 Ovarian Neoplasms 41 Multiple Myeloma 20 Fallopian Tube Neoplasms 13 Lymphoma 12 Sarcoma 11 Carcinoma, Ovarian Epithelial 11 Triple Negative Breast Neoplasms 8 Recurrence 8 Lymphoma, Large B-Cell, Diffuse 8 Neoplasms 7 Lymphoma, Non-Hodgkin 7 Hodgkin Disease 6 Prostatic Neoplasms 5 Neoplasms, Plasma Cell 5 Sarcoma, Ewing 4 Neoplasm Metastasis 4 Lymphoma, Mantle-Cell 4 Burkitt Lymphoma 4 Rhabdomyosarcoma 3 Pancreatic Neoplasms 3 Osteosarcoma 3 Lymphoma, T-Cell, Peripheral 3 Leiomyosarcoma 3 Breast Neoplasms, Male 3 Uterine Cervical Neoplasms 2 Solid Tumors 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2

Interventions

Saline Solution 2 Bevacizumab 2 senaparib 1 olaparib 1 niraparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Carboplatin 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡